Functional Endoscopic Sinus Surgery Market by Product (Endoscopes, Surgical Instruments, Navigation Systems), Procedure, Indication, Patient type - Global Forecast to 2029
세계의 기능적 내시경 부비강 수술 시장 규모는 예측 기간 동안 7.6%의 연평균 복합 성장률(CAGR)로 확대될 전망이며, 2024년의 12억 달러에서 2029년에는 17억 달러에 이를 것으로 예측되고 있습니다.
이 시장의 성장은 저침습 수술에 대한 수요가 증가하고 질병에 대한 의식이 높아지고 기술의 발전이 주요 요인입니다. AI의 출현은 기능적 내시경 부비강 수술의 시나리오를 바꾸어 환자 기록, 치료 결과를 포함한 대량의 데이터를 분석할 수 있게 되었기 때문에 귀중한 인사이트가 인출되어 의사 결정에 도움이 되었습니다. 따라서, 혁신적인 기술과 맞춤 치료 방법의 통합은 기능적 내시경 부비강 수술에서 환자의 결과를 현저하게 개선시켰습니다. 그러나 수술로 인한 관련 위험은 예측 기간 동안 기능적 내시경 부비강 수술 시장을 억제하는 것으로 보입니다.
| 조사 범위 |
| 조사 대상년도 |
2022-2029년 |
| 기준년 |
2023년 |
| 예측 기간 |
2024-2029년 |
| 검토 단위 |
금액(10억 달러) |
| 부문별 |
제품별, 수기별, 적응증별, 환자 유형별, 최종 사용자별, 지역별 |
| 대상 지역 |
북미, 유럽, 아시아태평양, 라틴아메리카, 중동, 아프리카, GCC |
기능적 내시경 부비강 수술 시장은 제품별로 내시경, 수술 기구, 내비게이션 시스템으로 구분됩니다. 2023년 시장 점유율은 수술 기구 분야가 가장 큽니다. 전문 이비인후과 및 내시경 부비동 수술센터 증가로 인해 기능적 내시경 부비강 수술에 사용되는 전용 수술 기구 수요가 증가하고 있으며, 수술기구 기술의 빈번한 업데이트와 제품의 발매가 행해지고 있습니다.
절차별로 기능적 내시경 부비강 수술 시장은 전두동 수술, 정골동 수술, 상악동 수술, 나비형 골동 수술 및 기타 수술로 구분됩니다. 상악동 수술 부문은 2023년 최대 시장 점유율을 차지했습니다. 이 부문의 큰 점유율은 상악동 수술 건수 증가, 인지도의 향상, 기술의 진보, 환자 수요에 의한 것으로 예상됩니다.
기능적 내시경 부비강 수술 시장은 최종 사용자별로는 병원 및 외래수술센터(ASC), 전문 클리닉으로 구분됩니다. 병원 및 외래수술센터(ASC) 부문은 2023년 기능적 내시경 부비강 수술 시장에서 가장 큰 점유율을 차지했습니다. 외래수술센터(ASC)에서 수행되는 부비동 수술의 수가 많아 건강 관리 인프라와 시설에 대한 투자가 증가하면이 최종 사용자 부문의 성장을 지원합니다.
이 보고서는 세계의 기능적 내시경 부비강 수술 시장을 조사했으며, 제품별, 수술별, 적응증별, 환자 유형별, 최종 사용자별, 지역별 동향 및 시장 진출기업 프로파일 등을 정리했습니다.
목차
제1장 서론
제2장 조사 방법
제3장 주요 요약
제4장 중요 인사이트
제5장 시장 개요
- 서문
- 시장 역학
- 가격 분석
- 특허 분석
- 밸류체인 분석
- 공급망 분석
- 생태계 분석
- Porter's Five Forces 분석
- 주요 이해관계자 및 구매 기준
- 규제 분석
- 무역 분석
- 기술 분석
- 주된 회의 및 이벤트(2024-2025년)
- 고객의 비즈니스에 영향을 미치는 동향 및 혼란
- 투자 및 자금조달 시나리오
- 기능적 내시경 부비강 수술 시장에서의 생성형 AI의 영향
제6장 기능적 내시경 부비강 수술 시장 : 제품별
제7장 기능적 내시경 부비강 수술 시장 : 수기별
- 서문
- 상악동 수술
- 사골동 수술
- 전두동 수술
- 나비형 골동 수술
- 기타
제8장 기능적 내시경 부비강 수술 시장 : 적응증별
- 서문
- 곰팡이성 부비동염
- 만성 부비동염
- 코 폴립
- 재발성 부비동염
- 기타
제9장 기능적 내시경 부비강 수술 시장 : 환자 유형별
제10장 기능적 내시경 부비강 수술 시장 : 최종 사용자별
- 서문
- 병원 및 외래수술센터(ASC)
- 전문 클리닉
제11장 기능적 내시경 부비강 수술 시장 : 지역별
- 서문
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC 국가
제12장 경쟁 구도
- 개요
- 주요 진입기업의 전략 및 비책
- 수익 분석
- 시장 점유율 분석
- 기업평가 매트릭스 : 주요 진입기업(2023년)
- 기업평가 매트릭스 : 스타트업 및 중소기업(2023년)
- 평가 및 재무지표
- 브랜드 및 제품 비교
- 경쟁 시나리오
제13장 기업 프로파일
- 주요 진출기업
- MEDTRONIC PLC
- STRYKER CORPORATION
- OLYMPUS CORPORATION
- B. BRAUN MELSUNGEN AG
- KARL STORZ
- CONMED CORPORATION
- TELEFLEX INCORPORATED
- INTEGRA LIFESCIENCES
- BRAINLAB AG
- RUDOLF MEDICAL GMBH CO. KG
- 기타 기업
- ATMOS MEDIZINTECHNIK
- INNOVIA MEDICAL
- SUTTER MEDIZINTECHNIK GMBH
- RZ MEDIZINTECHNIK
- ADVIN HEALTHCARE
- ECLERIS
- HENKE SASS WOLF
- JEDMED
- ENTERMED
- FIAGON GMBH
- CLARONAV KOLAHI INC.
- ADEPT MEDICAL
- MEDELEC SURGICAL
- HEAL FORCE BIO-MEDITECH HOLDINGS LIMITED
- COLLIN MEDICAL
제14장 부록
AJY
The global Functional endoscopic sinus surgery market is projected to reach USD 1.7 billion by 2029 from USD 1.2 billion in 2024, at a CAGR of 7.6% during the forecast period. The growth of this market is majorly driven by rise in demand for minimally invasive surgeries, growing awareness about the disease, and technological advancements. The emergence of AI have changed the scenario in FESS due to which large amount of data could be analysed including patient records, treatment outcomes, so that valuable insights could be drawn and will help in decision making. Thus, due to integrating innovative techniques and individualized treatment methods, patient outcomes have significantly improved in FESS. However, associated risks due to surgeries will restrain the FESS market during the forecast period.
| Scope of the Report |
|---|
| Years Considered for the Study | 2022-2029 |
| Base Year | 2023 |
| Forecast Period | 2024-2029 |
| Units Considered | Value (USD Billion) |
| Segments | By Product, procedure, indication, patient type, end user. |
| Regions covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa, GCC. |
"Surgical instruments segment accounted for the highest market share in the Functional endoscopic sinus surgery market, by product, during the forecast period."
The functional endoscopic sinus surgery market, by product, is segmented into endoscopes, surgical instruments, and navigation systems. The surgical instruments segment accounted for the largest market share in 2023. The growth in specialized ENT and endoscopic sinus surgery centers is increasing the demand for dedicated surgical instruments used in FESS and frequent updates and product launches in surgical instruments technology.
"Maxillary sinus surgery accounted for the larger market share in the Functional endoscopic sinus surgery market, by procedure, during the forecast period."
Based on procedure, the functional endoscopic sinus surgery market is segmented into frontal sinus surgery, ethmoid sinus surgery, maxillary sinus surgery, sphenoid sinus surgery, and other procedures. The maxillary sinus surgery segment accounted for the largest market share in 2023. The large share of this segment can be attributed due to the rise in number of maxillary sinus surgeries, growing awareness, advancements in technologies, and patient demand.
"Hospitals & ASCs accounted for the highest CAGR during the forecast period."
Based on the end user, the Functional endoscopic sinus surgery market is segmented into hospitals & ASCs, and specialty clinics. The hospitals & ASCs segment accounted for the largest share of the functional endoscopic sinus surgery market in 2023. Large number of sinus surgeries being performed in ASCs, growing investments in healthcare infrastructure and facilities are supporting the growth of this end-user segment.
"The North America segment accounted for the highest market share in the Functional endoscopic sinus surgery market, by region, during the forecast period."
Based on the region, the Functional endoscopic sinus surgery market is divided into North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC. North America region accounted for the largest share of the global Functional endoscopic sinus surgery market in 2023. This large share of North America is due to the strong healthcare system, presence of leading players, and innovation in technologies such as navigation systems and endoscopes.
Breakdown of supply-side primary interviews by company type, designation, and region:
- By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
- By Designation: C-level (30%), Director-level (20%), and Others (50%)
- By Region: North America (34%), Asia- Pacific (27%), Europe (23%), Latin America- (7%) and MEA-(5%), and GCC (4%).
Prominent companies include Medtronic plc (Ireland), Stryker Corporation (US), Olympus Corporation (Japan), B. Braun Melsungen Ag (Germany), KARL STORZ (Germany), CONMED Corporation (US), Teleflex Incorporated (US), Integra LifeSciences Holdings Corporation (US), Brainlab AG (Germany), and RUDOLF Medical GmbH + Co. Kg (Germany).
Research Coverage
This research report categorizes the Functional endoscopic sinus surgery market by product, procedure, indication, patient type, end user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the Functional endoscopic sinus surgery market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product launches, mergers and acquisitions, and recent developments associated with the Functional endoscopic sinus surgery market. Competitive analysis of upcoming startups in the Functional endoscopic sinus surgery market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall Functional endoscopic sinus surgery market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers (high prevalence of chronic sinusitis, growing preference for MIS, technological advancements, and rising awareness), restraints (risks involved in surgeries, the availability of nonsurgical treatments, and high procedural costs), opportunities (integration of AI and robotics in FESS and growing healthcare market in emerging economics), and challenges (shortage of skilled surgeons) influencing the growth of the Functional endoscopic sinus surgery market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the Functional endoscopic sinus surgery market.
- Market Development: Comprehensive information about lucrative markets - the report analyses the Functional endoscopic sinus surgery market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Functional endoscopic sinus surgery market
- Competitive Assessment: In-depth assessment of market ranking, growth strategies, and product offerings of leading players like Medtronic plc (Ireland), Stryker Corporation (US), Olympus Corporation (Japan), B. Braun Melsungen Ag (Germany), KARL STORZ (Germany), among others in the Functional endoscopic sinus surgery market strategies.
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.2.1 INCLUSIONS & EXCLUSIONS
- 1.3 STUDY SCOPE
- 1.3.1 MARKETS COVERED
- 1.3.2 REGIONS COVERED
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
- 1.4 STAKEHOLDERS
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.1.1 Secondary sources
- 2.1.2 PRIMARY DATA
- 2.1.2.1 Breakdown of primary interviews
- 2.1.2.2 Breakdown of primary interviews
- 2.2 MARKET SIZE ESTIMATION
- 2.2.1 APPROACH 1: BOTTOM-UP APPROACH
- 2.2.2 TOP-DOWN APPROACH
- 2.2.3 GEOGRAPHIC MARKET ASSESSMENT
- 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
- 2.4 MARKET SHARE ANALYSIS
- 2.5 STUDY ASSUMPTIONS
- 2.6 RISK ASSESSMENT
- 2.7 LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET OVERVIEW
- 4.2 ASIA PACIFIC: FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PROCEDURE (2023)
- 4.3 REGIONAL GROWTH OPPORTUNITIES IN FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET
- 4.4 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET: REGIONAL MIX
- 4.5 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 High prevalence of chronic sinusitis
- 5.2.1.2 Growing preference for MIS
- 5.2.1.3 Technological advancements
- 5.2.1.4 Rising awareness
- 5.2.2 RESTRAINTS
- 5.2.2.1 Risks associated with sinus surgeries
- 5.2.2.2 Availability of nonsurgical treatments for chronic sinusitis
- 5.2.2.3 High procedural costs
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 Integration of AI and robotics in FESS
- 5.2.3.2 Growing healthcare market in emerging economies
- 5.2.4 CHALLENGES
- 5.2.4.1 Shortage of skilled professionals
- 5.2.5 TRENDS
- 5.2.5.1 Emergence of minimally invasive in-office sinus surgery
- 5.2.5.2 Increased use of artificial intelligence (AI)
- 5.2.5.3 Development of new surgical techniques
- 5.2.5.4 Personalized treatment plans
- 5.2.5.5 Improved patient outcomes
- 5.3 PRICING ANALYSIS
- 5.3.1 AVERAGE SELLING PRICE TREND OF FESS PRODUCTS
- 5.3.2 AVERAGE SELLING PRICE OF FESS PRODUCTS, BY REGION
- 5.4 PATENT ANALYSIS
- 5.4.1 LIST OF MAJOR PATENTS
- 5.5 VALUE CHAIN ANALYSIS
- 5.6 SUPPLY CHAIN ANALYSIS
- 5.7 ECOSYSTEM ANALYSIS
- 5.7.1 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET: ROLE IN ECOSYSTEM
- 5.8 PORTER'S FIVE FORCES ANALYSIS
- 5.8.1 THREAT OF NEW ENTRANTS
- 5.8.2 THREAT OF SUBSTITUTES
- 5.8.3 BARGAINING POWER OF SUPPLIERS
- 5.8.4 BARGAINING POWER OF BUYERS
- 5.8.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.9.2 BUYING CRITERIA
- 5.1 REGULATORY ANALYSIS
- 5.10.1 REGULATORY LANDSCAPE
- 5.10.1.1 US
- 5.10.1.2 Europe
- 5.10.1.3 India
- 5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.11 TRADE ANALYSIS
- 5.12 TECHNOLOGY ANALYSIS
- 5.12.1 KEY TECHNOLOGIES
- 5.12.1.1 Endoscopes
- 5.12.1.2 Navigation systems
- 5.12.2 ADJACENT TECHNOLOGIES
- 5.12.2.1 Balloon sinus dilation devices
- 5.13 KEY CONFERENCES AND EVENTS IN 2024-2025
- 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.15 INVESTMENT AND FUNDING SCENARIO
- 5.16 IMPACT OF GENERATIVE AI ON FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET
6 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PRODUCT
- 6.1 INTRODUCTION
- 6.2 SURGICAL INSTRUMENTS
- 6.2.1 SURGICAL INSTRUMENTS TO HOLD LARGEST MARKET SHARE
- 6.3 ENDOSCOPES
- 6.3.1 SINUSCOPES
- 6.3.1.1 Sinuscopes to hold largest share of FESS endoscopes market
- 6.3.2 RHINOSCOPES
- 6.3.2.1 Greater flexibility over sinuscopes to support market growth
- 6.4 NAVIGATION SYSTEMS
- 6.4.1 OPTICAL NAVIGATION SYSTEMS
- 6.4.2 ELECTROMAGNETIC NAVIGATION SYSTEMS
- 6.4.2.1 Advantageous over optical navigation systems to drive market
7 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PROCEDURE
- 7.1 INTRODUCTION
- 7.2 MAXILLARY SINUS SURGERY
- 7.2.1 INVASIVE NATURE TO AFFECT ADOPTION OF MAXILLARY SINUS SURGERY
- 7.3 ETHMOID SINUS SURGERY
- 7.3.1 EFFECTIVENESS OF TREATMENT TO DRIVE ADOPTION
- 7.4 FRONTAL SINUS SURGERY
- 7.4.1 INCREASING PREVALENCE OF CHRONIC RHINOSINUSITIS TO DRIVE MARKET
- 7.5 SPHENOID SINUS SURGERY
- 7.5.1 HIGHER INDICATIONS FOR SURGERY TO BOOST ADOPTION
- 7.6 OTHER PROCEDURES
8 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY INDICATION
- 8.1 INTRODUCTION
- 8.2 FUNGAL SINUSITIS
- 8.2.1 RISING EXPOSURE TO FUNGAL SPORES TO DRIVE MARKET
- 8.3 CHRONIC SINUSITIS
- 8.3.1 GROWING PREVALENCE OF CRS TO SUPPORT MARKET GROWTH
- 8.4 NASAL POLYPOSIS
- 8.4.1 WIDE PREVALENCE OF CAUSATIVE/CONTRIBUTING FACTORS TO DRIVE MARKET
- 8.5 RECURRENT SINUSITIS
- 8.5.1 GROWING PREVALENCE OF COLD TO SUPPORT MARKET GROWTH
- 8.6 OTHER INDICATIONS
9 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY PATIENT TYPE
- 9.1 INTRODUCTION
- 9.2 ADULT PATIENTS
- 9.2.1 ADULT PATIENTS TO DOMINATE MARKET FOR FESS
- 9.3 PEDIATRIC PATIENTS
- 9.3.1 HIGH PREVALENCE OF SINUSITIS IN CHILDREN TO DRIVE MARKET
10 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY END USER
- 10.1 INTRODUCTION
- 10.2 HOSPITALS & AMBULATORY SURGERY CENTERS
- 10.2.1 HOSPITALS & ASCS TO FORM LARGEST AND FASTEST-GROWING END-USER SEGMENT
- 10.3 SPECIALTY CLINICS
- 10.3.1 FASTER RECOVERY TIME AND COST-EFFECTIVENESS TO SUPPORT GROWTH
11 FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET, BY REGION
- 11.1 INTRODUCTION
- 11.2 NORTH AMERICA
- 11.2.1 US
- 11.2.1.1 US to dominate North American market
- 11.2.2 CANADA
- 11.2.2.1 Rising geriatric population and associated increase in prevalence of CRS to support market growth
- 11.3 EUROPE
- 11.3.1 GERMANY
- 11.3.1.1 Germany to hold largest market share in Europe
- 11.3.2 UK
- 11.3.2.1 High R&D expenditure to drive market
- 11.3.3 FRANCE
- 11.3.3.1 High burden of chronic sinusitis to propel adoption of FESS
- 11.3.4 ITALY
- 11.3.4.1 Growing geriatric population to support adoption of FESS products
- 11.3.5 SPAIN
- 11.3.5.1 Rising healthcare expenditure to drive market for FESS
- 11.3.6 REST OF EUROPE
- 11.4 ASIA PACIFIC
- 11.4.1 CHINA
- 11.4.1.1 China to hold largest market share in APAC
- 11.4.2 JAPAN
- 11.4.2.1 Research initiatives to support market growth in Japan
- 11.4.3 INDIA
- 11.4.3.1 Increasing investments in research to support market growth
- 11.4.4 REST OF ASIA PACIFIC
- 11.5 LATIN AMERICA
- 11.5.1 BRAZIL
- 11.5.1.1 Brazil to hold largest share of LATAM market till 2029
- 11.5.2 MEXICO
- 11.5.2.1 Rising geriatric population to support market growth
- 11.5.3 REST OF LATIN AMERICA
- 11.6 MIDDLE EAST & AFRICA
- 11.6.1 RISING HEALTHCARE INVESTMENTS TO SUPPORT MARKET GROWTH
- 11.7 GCC COUNTRIES
- 11.7.1 UAE
- 11.7.1.1 Growing number of hospitals to drive market
- 11.7.2 SAUDI ARABIA
- 11.7.2.1 Healthcare infrastructural improvements to support market growth
- 11.7.3 OTHER GCC COUNTRIES
12 COMPETITIVE LANDSCAPE
- 12.1 OVERVIEW
- 12.2 KEY PLAYER STRATEGY/RIGHT TO WIN
- 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN FUNCTIONAL ENDOSCOPIC SINUS SURGERY MARKET
- 12.3 REVENUE ANALYSIS
- 12.4 MARKET SHARE ANALYSIS
- 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 12.5.1 STARS
- 12.5.2 EMERGING LEADERS
- 12.5.3 PERVASIVE PLAYERS
- 12.5.4 PARTICIPANTS
- 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
- 12.5.5.1 Company footprint
- 12.5.5.2 Product footprint
- 12.5.5.3 Regional footprint
- 12.5.5.4 Procedure footprint
- 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 12.6.1 PROGRESSIVE COMPANIES
- 12.6.2 RESPONSIVE COMPANIES
- 12.6.3 DYNAMIC COMPANIES
- 12.6.4 STARTING BLOCKS
- 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
- 12.7 VALUATION & FINANCIAL METRICS
- 12.8 BRAND/PRODUCT COMPARISON
- 12.9 COMPETITIVE SCENARIO
- 12.9.1 PRODUCT LAUNCHES & APPROVALS
- 12.9.2 DEALS
- 12.9.3 EXPANSIONS
13 COMPANY PROFILES
- 13.1 KEY PLAYERS
- 13.1.1 MEDTRONIC PLC
- 13.1.1.1 Business overview
- 13.1.1.2 Products offered
- 13.1.1.3 Recent developments
- 13.1.1.4 MnM view
- 13.1.1.4.1 Right to win
- 13.1.1.4.2 Strategic choices
- 13.1.1.4.3 Weaknesses & competitive threats
- 13.1.2 STRYKER CORPORATION
- 13.1.2.1 Business overview
- 13.1.2.2 Products offered
- 13.1.2.3 Recent developments
- 13.1.2.4 MnM view
- 13.1.2.4.1 Right to win
- 13.1.2.4.2 Strategic choices
- 13.1.2.4.3 Weaknesses & competitive threats
- 13.1.3 OLYMPUS CORPORATION
- 13.1.3.1 Business overview
- 13.1.3.2 Products offered
- 13.1.3.3 Recent developments
- 13.1.3.3.1 Product approvals
- 13.1.3.4 MnM view
- 13.1.3.4.1 Right to win
- 13.1.3.4.2 Strategic choices
- 13.1.3.4.3 Weaknesses & competitive threats
- 13.1.4 B. BRAUN MELSUNGEN AG
- 13.1.4.1 Business overview
- 13.1.4.2 Products offered
- 13.1.5 KARL STORZ
- 13.1.5.1 Business overview
- 13.1.5.2 Products offered
- 13.1.6 CONMED CORPORATION
- 13.1.6.1 Business overview
- 13.1.6.2 Products offered
- 13.1.7 TELEFLEX INCORPORATED
- 13.1.7.1 Business overview
- 13.1.7.2 Products offered
- 13.1.8 INTEGRA LIFESCIENCES
- 13.1.8.1 Business overview
- 13.1.8.2 Products offered
- 13.1.8.3 Recent developments
- 13.1.9 BRAINLAB AG
- 13.1.9.1 Business overview
- 13.1.9.2 Products offered
- 13.1.10 RUDOLF MEDICAL GMBH + CO. KG
- 13.1.10.1 Business overview
- 13.1.10.2 Products offered
- 13.2 OTHER PLAYERS
- 13.2.1 ATMOS MEDIZINTECHNIK
- 13.2.2 INNOVIA MEDICAL
- 13.2.3 SUTTER MEDIZINTECHNIK GMBH
- 13.2.4 RZ MEDIZINTECHNIK
- 13.2.5 ADVIN HEALTHCARE
- 13.2.6 ECLERIS
- 13.2.7 HENKE SASS WOLF
- 13.2.8 JEDMED
- 13.2.9 ENTERMED
- 13.2.10 FIAGON GMBH
- 13.2.11 CLARONAV KOLAHI INC.
- 13.2.12 ADEPT MEDICAL
- 13.2.13 MEDELEC SURGICAL
- 13.2.14 HEAL FORCE BIO-MEDITECH HOLDINGS LIMITED
- 13.2.15 COLLIN MEDICAL
14 APPENDIX
- 14.1 DISCUSSION GUIDE
- 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 14.3 CUSTOMIZATION OPTIONS
- 14.4 RELATED REPORTS
- 14.5 AUTHOR DETAILS
